ArticleJournal of clinical pharmacy and therapeutics2020

Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.

Hiroaki Ikesue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.